Patents Examined by Valerie Bertoglio
  • Patent number: 9049850
    Abstract: Nucleic acid molecules encoding an insulin-like factor of the androgenic gland of the freshwater prawn Macrobrachium rosenbergii (M. rosenbergii) are disclosed. Also disclosed are methods of silencing the expression of the insulin-like factor gene in decapod crustaceans order, particularly in M. rosenbergii, useful for producing male monosex populations.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: June 9, 2015
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Amir Sagi, Tomer Ventura
  • Patent number: 8951510
    Abstract: A polypeptide comprising a polypeptide consisting of an amino acid sequence shown in SEQ ID NO: 5 of Sequence Listing or a polypeptide consisting of an amino acid sequence having deletion, addition, insertion or substitution of one to several amino acid residues in the sequence, the polypeptide being capable of constituting an HLA-A24-restricted, MAGE-A4143-151-specific T cell receptor together with a polypeptide consisting of an amino acid sequence shown in SEQ ID NO: 2 of Sequence Listing.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: February 10, 2015
    Assignees: Mie University, Takara Bio Inc.
    Inventors: Hiroshi Shiku, Atsunori Hiasa, Satoshi Okumura, Hiroaki Naota, Yoshihiro Miyahara
  • Patent number: 8900860
    Abstract: The present invention relates to a novel method for expanding mesenchymal stem cells (MSCs) in low-density and hypoxic condition as compared to normal air conditions traditionally used in cell culture. The present method provides rapid and efficient expansion of human MSCs without losing cellular proliferation and stem cell properties, including increase in proliferation, decrease in senescence, and increase in differentiation potential both in vitro and in vivo. The expanded MSCs by the present method may maintain normal karyotyping, and will not form tumor when transplanted into mammal.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: December 2, 2014
    Assignee: National Yang-Ming University
    Inventor: Shih-Chieh Hung
  • Patent number: 8242326
    Abstract: The present invention is directed to fish whose genome has integrated therein an oncogenic nucleic acid operably linked to a promoter. Methods of making the fish and methods for their use are also provided. The fish may advantageously be utilized in methods of screening for drugs or agents that modulate oncogene-mediated neoplastic or hyperplastic transformation, or that modulate sensitivity to chemotherapy or radiation therapy. Immortal tumor cells lines, methods of making immortal tumor cell lines and methods of their use are also provided.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: August 14, 2012
    Assignee: Temasek Life Sciences Laboratory Limited
    Inventors: Sergey Parinov, Alexander Emelyanov
  • Patent number: 8222383
    Abstract: Disclosed are DNA encoding a polypeptide which can modulate the activity of a muscle-specific tyrosine kinase, and others. The DNA is selected from the following members (a) to (d): (a) DNA comprising a specific nucleotide sequence; (b) DNA comprising a nucleotide sequence capable of hybridizing with a specific nucleotide sequence under stringent conditions; (c) DNA comprising a nucleotide sequence encoding an amino acid sequence having the substitution, deletion and/or addition of one or several amino acid residues in a specific amino acid sequence; and (d) DNA comprising a nucleotide sequence having 90% or higher homology to a specific nucleotide sequence.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: July 17, 2012
    Assignee: National University Corporation, Tokyo Medical and Dental University
    Inventors: Yuji Yamanashi, Osamu Higuchi, Kumiko Okada, Akane Inoue
  • Patent number: 8030287
    Abstract: In this application is described a novel DNA vaccine for Spring viremia of carp virus. The candidate vaccine a SVCV glycoprotein (G) gene from the North Carolina isolate. The DNA vaccine provides protection in vaccinated fish against challenge with the SVCV.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: October 4, 2011
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Eveline J. Emmenegger, Gael Kurath
  • Patent number: 7423135
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: September 9, 2008
    Assignee: Genzyme Corporation
    Inventors: Scott D. Estes, Weiqun Zhang